Abstract:Background Toll-like receptors (TLRs) are important components of the innate and adaptive immune systems, and abnormal TLR expression has been linked to a variety of cancers. However, there was a lack of clarity on the association of TLR stimulation with the carcinogenesis of cancer. The study's goal was to analyse the clinical importance of TLRs expression at the mRNA level in pan-cancer datasets, as well as the link between TLR expression and carcinogenesis, progression, and clinical prognosis.Methods The expression profile of TLRs derived from UCSC pan-cancer data was analysed in multiple dimensions, including clinical analysis, immunological subtype analysis, tumour microenvironment (TME) analysis, tumour stem cell correlation analysis, and drug sensitivity analysis. Additionally, we analyse protein-protein interactions, functional enrichment, and chromatin accessibility, as well as TLR expression in single-cell sequencing data.Results Our multi-omics analysis results imply that TLRs may operate as a biological marker for carcinogenesis and progression, a potential target for anti-tumour therapy, and a prognostic biomarker, laying the theoretical groundwork for future translational medicine research.Conclusion TLRs are involved in the formation of malignancies and can be explored in further detail as potential prognostic indicators. Key MessagesToll-like receptors (TLRs) are key factors in the process of the innate and adaptive immune response, and their aberrant expression of TLRs have been widely reported in various cancer. However, the association between TLRs stimulation and tumorigenesis of cancer has not been well clarified.In this study, in the pan-cancer data, integrated TLR family gene expression analysis, clinical correlation analysis, immune subtype correlation analysis, tumour microenvironment correlation analysis, tumour stem cell correlation analysis, and drug sensitivity correlation analysis were performed.TLRs play an important role in the development of tumours and can be studied in depth as potential prognostic markers.

Tlr4 Signaling Promotes The Expression Of Vegf And Tgf Beta(1) In Human Prostate Epithelial Pc3 Cells Induced By Lipopolysaccharide

TLR4 Signaling Promotes Immune Escape of Human Lung Cancer Cells by Inducing Immunosuppressive Cytokines and Apoptosis Resistance.

Toll-like Receptor 3 and Tumor Immunity

Toll-like Receptor 4 Signaling Promotes Invasion of Hepatocellular Carcinoma Cells Through MKK4/JNK Pathway.

Toll-like Receptor 9 Agonists Promote IL-8 and TGF-β1production Via Activation of Nuclear Factor Κb in PC-3 Cells

Upregulation of TLR5 Indicates a Favorable Prognosis in Prostate Cancer

The Expression and Clinical Significance of TLR4 in Human Prostate Cancer

Toll-like receptor 10 (TLR10) exhibits suppressive effects on inflammation of prostate epithelial cells.

Alterations of Serum Cathepsins B and L in Pre-Eclampsia

The Role of Toll-Like Receptors (tlrs) in Pan-Cancer

Lps/Tlr4 Signaling Enhances Tgf-Beta Response Through Downregulating Bambi During Prostatic Hyperplasia

Toll-like receptor 4 ligation confers chemoresistance to docetaxel on PC-3 human prostate cancer cells

Regulation Of Migration And Invasion By Toll-Like Receptor-9 Signaling Network In Prostate Cancer

Small Interfering RNA-directed Targeting of Toll-like Receptor 4 Inhibits Human Prostate Cancer Cell Invasion, Survival, and Tumorigenicity.

TLR4 Signaling Promotes Immune Escape of Human Colon Cancer Cells by Inducing Immunosuppressive Cytokines and Apoptosis Resistance

Toll-Like Receptor 4 Prompts Human Breast Cancer Cells Invasiveness via Lipopolysaccharide Stimulation and Is Overexpressed in Patients with Lymph Node Metastasis

Toll-Like Receptors and Prostate Cancer

LPS/TLR4 Signaling Enhances TGF-β Response Through Downregulating BAMBI During Prostatic Hyperplasia

TLR4 Promotes Breast Cancer Metastasis Via Akt/GSK3β/β-Catenin Pathway Upon LPS Stimulation.

Toll-like Receptor 4 Signaling Promotes Epithelial-Mesenchymal Transition in Human Hepatocellular Carcinoma Induced by Lipopolysaccharide

Inflammation Induced by Lipopolysaccharide Advanced Androgen Receptor Expression and Epithelial-Mesenchymal Transition Progress in Prostatitis and Prostate Cancer.